In Vitro and In Vivo investigation of the angiogenic effects of liraglutide during islet transplantation

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Langlois, Allan ^a   Mura, Carole ^a   Bietiger, William ^a   Seyfritz, Elodie ^a   Dollinger, Camille ^a   Peronet, Claude ^a   Maillard, Elisa ^a   Pinget, Michel ^a,b   Jeandidier, Nathalie ^a,b   Sigrist, Séverine ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSULIN GLARGINE; LIRAGLUTIDE; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR A; VASCULOTROPIN; ANGIOGENIC FACTOR; HIF1A PROTEIN, RAT; MTOR PROTEIN, RAT; PLATELET DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR A; TARGET OF RAPAMYCIN KINASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GRAFT SURVIVAL; IN VITRO STUDY; IN VIVO STUDY; MALE; METABOLIC REGULATION; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION; WEIGHT GAIN; ANIMAL; LEWIS RAT; METABOLISM; PANCREAS ISLET; VASCULARIZATION; WISTAR RAT;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LIRAGLUTIDE; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, INBRED LEW; RATS, WISTAR; TOR SERINE-THREONINE KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84962233220     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147068     Document Type: Article

References (40)

1. Pepper AR, Gala-Lopez B, Ziff O., Shapiro A.M. (2013) Revascularization of transplanted pancreatic islets and role of the transplantation site. Clin Dev Immunol 2013: 352315. doi: 10.1155/2013/352315 PMID: 24106517
2. Shapiro AM, Lakey JR, Ryan E.A., Korbutt GS, Toth E, Warnock GL et al. (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343: 230-8. PMID: 10911004
3. Coppens V, Heremans Y, Leuckx G., Suenens K, Jacobs-Tulleneers-Thevissen D, Verdonck K et al. (2013) Human blood outgrowth endothelial cells improve islet survival and function when co-transplanted in a mouse model of diabetes. Diabetologia 56: 382-90. doi: 10.1007/s00125-012-2754-3 PMID: 23090187
4. Davalli AM, Scaglia L, Zangen D.H., Hollister J., Bonner-Weir S, Weir GC (1996) Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 45: 1161-7. PMID: 8772716
5. Emamaullee JA, Shapiro A.M. (2006) Interventional strategies to prevent beta-cell apoptosis in islet transplantation. Diabetes 55:1907-14. PMID: 16804057
6. Jansson L, Carlsson P.O. (2002) Graft vascular function after transplantation of pancreatic islets. Diabetologia 45: 749-63. PMID: 12107718
7. Wittig C, Laschke MW, Scheuer C, Menger MD (2013) Incorporation of bone marrow cells in pancreatic pseudoislets improves posttransplant vascularization and endocrine function. PLoSOne 8: e69975. doi: 10.1371/journal.pone.0069975 PMID: 23875013
8. Sigrist S, Mechine-Neuville A, Mandes K., Calenda V, Braun S, Legeay G., et al. (2003) Influence of VEGF on the viability of encapsulated pancreatic rat islets after transplantation in diabetic mice. Cell Transplant 12: 627-35. PMID: 14579931
9. Yancopoulos GD, Davis S, Gale N.W., Rudge JS, Wiegand SJ, Holash J. (2000) Vascular-specific growth factors and blood vessel formation. Nature 407:242-8. PMID: 11001067
10. Zhang N, Richter A, Suriawinata J., Harbaran S, Altomonte J, Cong L et al. (2004) Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes 53: 963-70. PMID: 15047611
11. Samikannu B, Chen C, Lingwal N., Padmasekar M, Engel FB, Linn T (2013) Dipeptidyl Peptidase IV Inhibition Activates CREB and Improves Islet Vascularization through VEGF-A/VEGFR-2 Signaling Pathway. PLoS One 8: e82639. doi: 10.1371/journal.pone.0082639 PMID: 24349326
12. Cross SE, Richards SK, Clark A, Benest A.V., Bates DO, Mathieson PWet al. (2007) Vascular endothelial growth factor as a survival factor for human islets: effect of immunosuppressive drugs. Diabetologia 50:1423-32. PMID: 17476476
13. Ryan EA, Paty BW, Senior P.A., Bigam D., Alfadhli E, Kneteman NM et al. (2005) Five-yearfollow-up after clinical islet transplantation. Diabetes 54: 2060-9. PMID: 15983207
14. Langlois A, Bietiger W, Seyfritz E., Maillard E, Vivot K, Peronet C et al (2011) Improvement of rat islet viability during transplantation: validation of pharmacological approach to induce VEGF overexpression. Cell Transplant 20:1333-42. doi: 10.3727/096368910X557182 PMID: 21294962
15. Narang AS, Sabek O, Gaber AO, Mahato RI (2006) Co-expression of vascular endothelial growth factor and interleukin-1 receptor antagonist improves human islet survival and function. Pharm Res 23: 1970-82. PMID: 16906455
16. Langlois A, Bietiger W, Sencier MC, Maillard E, Pinget M, Kessler L et al. (2009) Adenoviral infection or deferoxamine? Two approaches to overexpress VEGF in beta-cell lines. J Drug Target 17: 415-22. doi: 10.1080/10611860902929832 PMID: 19527112
17. Bloch K, Vennang J, Lazard D., Vardi P. (2012) Different susceptibility of rat pancreatic alpha and beta cells to hypoxia. Histochem Cell Biol 137: 801-10. doi: 10.1007/s00418-012-0925-4 PMID: 22310982
18. Sato K, Kameda M, Yasuhara T, Agari T, Baba T, Wang F et al. (2013) Neuroprotective effects of liraglutide for stroke model of rats. Int J Mol Sci 14: 21513-24. doi: 10.3390/ijms141121513 PMID: 24177570
19. Knudsen LB, Nielsen PF, Huusfeldt P.O., Johansen NL, Madsen K, Pedersen FZet al. (2000) Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration. J MedChem 43:1664-9. PMID: 10794683
20. Kang HM, Kang Y, Chun HJ, Jeong JW, Park C (2013) Evaluation of the in vitro and in vivo angiogenic effects of exendin-4. Biochem Biophys Res Commun 434:150-4. doi: 10.1016/j.bbrc.2013.03.053 PMID: 23541581
21. Buse JB, Rosenstock J, Sesti G., Schmidt WE, Montanya E, Brett JH et al. (2009) Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet 374: 39-47. doi: 10.1016/S0140-6736(09)60659-0 PMID: 19515413
22. Merani S, Truong W, Emamaullee J.A., Toso C., Knudsen LB, Shapiro AM.(2008) Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice. Endocrinology 149: 4322-8. doi: 10.1210/en.2008-0501 PMID: 18511515
23. Emamaullee JA, Merani S, Toso C., Kin T, Al-Saif F, Truong W et al. (2009) Porcine marginal mass islet autografts resist metabolic failure over time and are enhanced by early treatment with liraglutide. Endocrinology 150: 2145-52. doi: 10.1210/en.2008-1116 PMID: 19131571
24. Toso C, McCall M, Emamaullee J, Merani S, Davis J, Edgar R et al. (2010) Liraglutide, along-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture. Transpl Int 23: 259-65. doi: 10.1111/j.1432-2277.2009.00984.x PMID: 19821955
25. Sutton R, Peters M, McShane P., Gray DW, Morris P.J. (1986) Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation 42: 689-91. PMID: 3024372
26. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-54. PMID: 942051
27. Livak KJ, Schmittgen T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods: 25: 402-8. PMID: 11846609
28. Cornu M, Thorens B. (2009) GLP-1 protects beta-cells against apoptosis by enhancing the activity of an IGF-2/IGF1-receptor autocrine loop. Islets 1: 280-2. doi: 10.4161/isl.1.3.9932 PMID: 21099285
29. Padmasekar M, Lingwal N, Samikannu B, Chen C, Sauer H, Linn T (2013) Exendin-4 protects hypoxic islets from oxidative stress and improves islet transplantation outcome. Endocrinology 154:1424-33
30. Jimenez-Feltstrom J, Lundquist I, Salehi A (2005) Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP/PKA pathway. Cell Tissue Res 319: 221-30.
31. Nishimura R, Ushiyama A, Sekiguchi S., Fujimori K, Ohuchi N Satomi S et al. (2013) Effects of glucagon-like peptide 1 analogue on the early phase of revascularization of transplanted pancreatic islets in a subcutaneous site. Transplant Proc 45:1892-4. doi: 10.1016/j.transproceed.2013.01.047 PMID: 23769065
32. Riddle RC, Khatri R, Schipani E., Clemens T.L. (2009) Role of hypoxia-inducible factor-1alpha in angiogenic-osteogenic coupling. J Mol Med (Berl) 87: 583-90.
33. Barlow AD, Nicholson ML, Herbert T.P. (2013) Evidence for rapamycin toxicity in pancreatic beta-cells and a review of the underlying molecular mechanisms. Diabetes 62: 2674-82. doi: 10.2337/db13-0106 PMID: 23881200
34. Carmeliet P (2004) Manipulating angiogenesis in medicine. J Intern Med 255: 538-61. PMID: 15078497
35. Miao G, Ostrowski RP, Mace J, Hough J, Hopper A, Peverini R et al. (2006) Dynamic production of hypoxia-inducible factor-1alpha in early transplanted islets. Am J Transplant 6: 2636-43. PMID: 17049056
36. Stokes RA, Cheng K, Deters N., Lau SM, Hawthorne WJ, O'Connell PJ et al. (2013) Hypoxia-inducible factor-1alpha (HIF-1alpha) potentiates beta-cell survival after islet transplantation of human and mouse islets. Cell Transplant 22: 253-66. doi: 10.3727/096368912X647180 PMID: 22710383
37. Karar J, Maity A. (2011) PI3K/AKT/mTOR Pathway in Angiogenesis. Front Mol Neurosci 4: 51. doi: 10.3389/fnmol.2011.00051 PMID: 22144946
38. Jiang BH, Jiang G, Zheng J.Z., Lu Z., Hunter T, Vogt P.K. (2001) Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ 12: 363-9. PMID: 11457733
39. Ansari MJ, Fiorina P, Dada S, Guleria I, Ueno T, Yuan X et al. (2008) Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice. Clin Immunol 126:140-7. PMID: 17889619
40. Tezza S, Ben Nasr M, Vergani A, ValderramaVasquez A, Maestroni A, Abdi R et al. (2015) Novel immunological strategies for islet transplantation. Pharmacol Res 98: 69-75. doi: 10.1016/j.phrs.2014.06.016 PMID: 25014184